(IN BRIEF) DPI, BII, and the EBRD have reached a binding agreement to fully exit their investment in KELIX bio, a pan-African biopharmaceutical platform, through its acquisition by Mubadala Investment Company. Founded in 2020, KELIX bio has rapidly grown to … Read the full press release
Posted in Banks, Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged acquisition, Africa, Alhadi Alwazir, British International Investment (BII), Development Partners International (DPI), EBRD, Essam Farouk, Frederic Lucenet, Hocine Sidi Said, KELIX bio, Mubadala, partnership, pharmaceuticals, Samir Abhyankar, Sofiane Lahmar, sustainability
(IN BRIEF) TotalEnergies, in collaboration with Global Infrastructure Partners (GIP), NextDecade Corporation, GIC, and Mubadala, has reached the final investment decision (FID) to develop phase 1 of the Rio Grande LNG (RGLNG) project in South Texas. The initial phase includes … Read the full press release
Posted in Business, Energy, Gas & Oil, Financial, France, Industrial, Infrastructure & Utilities, Investment, Management, News
Tagged Bechtel, GIC, Global Infrastructure Partners (GIP), investment, Matt Schatzman, Mubadala, NextDecade Corporation, partnership, Patrick Pouyanné, Rio Grande LNG Project, South Texas, TotalEnergies
Solvay and Mubadala create joint venture in UAE to expand 777X supply Brussels, Seattle, Abu Dhabi, 13-Jul-2016 — /EuropaWire/ — Solvay and Mubadala Development Company, the Abu Dhabi-based investment and development company, are further strengthening their solid strategic relationship with … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
